Company news

Everest Medicines Ltd. news in 2024

Everest Medicines Ltd.'s news releases, calls and decks from 2024, newest first.

View company

Everest Medicines Announces the First Prescription of VELSIPITY(R) in the Greater Bay Area

December 19, 2024

Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy

December 4, 2024

Decks in 2024